63 related articles for article (PubMed ID: 17982636)
21. [Construction of a lentiviral vector for RNA interference of human CDH22 gene and its gene silencing effect in SW480 cells].
Zhou J; Li JM; Yang FD; Liu YH; Ding YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):589-92. PubMed ID: 18495598
[TBL] [Abstract][Full Text] [Related]
22. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
23. ING4 induces cell growth inhibition in human lung adenocarcinoma A549 cells by means of Wnt-1/beta-catenin signaling pathway.
Li X; Cai L; Liang M; Wang Y; Yang J; Zhao Y
Anat Rec (Hoboken); 2008 May; 291(5):593-600. PubMed ID: 18399550
[TBL] [Abstract][Full Text] [Related]
24. Carbon-ion beam irradiation effectively suppresses migration and invasion of human non-small-cell lung cancer cells.
Akino Y; Teshima T; Kihara A; Kodera-Suzumoto Y; Inaoka M; Higashiyama S; Furusawa Y; Matsuura N
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):475-81. PubMed ID: 19735871
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of MDR1 expression by retinol treatment increases sensitivity to etoposide (VP16) in human neoplasic cell line.
Klamt F; Passos DT; Castro MA; Gelain DP; Grivicich I; Moreira JC
Toxicol In Vitro; 2008 Jun; 22(4):873-8. PubMed ID: 18282684
[TBL] [Abstract][Full Text] [Related]
26. Targeting MDR1 gene: synthesis and cellular study of modified daunomycin-triplex-forming oligonucleotide conjugates able to inhibit gene expression in resistant cell lines.
Stierlé V; Duca M; Halby L; Senamaud-Beaufort C; Capobianco ML; Laigle A; Jollès B; Arimondo PB
Mol Pharmacol; 2008 May; 73(5):1568-77. PubMed ID: 18299310
[TBL] [Abstract][Full Text] [Related]
27. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.
Tabuchi Y; Matsuoka J; Gunduz M; Imada T; Ono R; Ito M; Motoki T; Yamatsuji T; Shirakawa Y; Takaoka M; Haisa M; Tanaka N; Kurebayashi J; Jordan VC; Naomoto Y
Int J Oncol; 2009 Feb; 34(2):313-9. PubMed ID: 19148464
[TBL] [Abstract][Full Text] [Related]
28. [Construction of a lentiviral vector for RNA interference of PRL-3 gene and its stable expression in SW480 cells].
Liu YH; Li JM; Zhou J; Ding YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):509-12. PubMed ID: 18495578
[TBL] [Abstract][Full Text] [Related]
29. MDR1/P-gp and VEGF synergistically enhance the invasion of Hep-2 cells with multidrug resistance induced by taxol.
Li L; Jiang AC; Dong P; Wang H; Xu W; Xu C
Ann Surg Oncol; 2009 May; 16(5):1421-8. PubMed ID: 19247716
[TBL] [Abstract][Full Text] [Related]
30. Focused PCR screen reveals p53 dependence of nitric oxide-induced apoptosis and up-regulation of maspin and plasminogen activator inhibitor-1 in tumor cells.
Lim S; Hung AC; Porter AG
Mol Cancer Res; 2009 Jan; 7(1):55-66. PubMed ID: 19147537
[TBL] [Abstract][Full Text] [Related]
31. Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells.
Glienke W; Maute L; Wicht J; Bergmann L
Eur J Cancer; 2009 Mar; 45(5):874-80. PubMed ID: 19196508
[TBL] [Abstract][Full Text] [Related]
32. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
[TBL] [Abstract][Full Text] [Related]
33. Colony growth suppression by tumor suppressor genes.
Wu GS
Methods Mol Biol; 2003; 223():207-10. PubMed ID: 12777731
[No Abstract] [Full Text] [Related]
34. Targeting loss of tumor suppressors for cancer therapeutics.
Prosperi JR; Goss KH
Curr Drug Targets; 2014 Jan; 15(1):1. PubMed ID: 24428573
[No Abstract] [Full Text] [Related]
35. Drug-Resistant Breast Cancer: Dwelling the Hippo Pathway to Manage the Treatment.
Kaur S; Najm MZ; Khan MA; Akhter N; Shingatgeri VM; Sikenis M; Sadaf ; Aloliqi AA
Breast Cancer (Dove Med Press); 2021; 13():691-700. PubMed ID: 34938116
[TBL] [Abstract][Full Text] [Related]
36. The Hippo Signaling Pathway in Drug Resistance in Cancer.
Zeng R; Dong J
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33467099
[TBL] [Abstract][Full Text] [Related]
37. YAP/TAZ Signaling and Resistance to Cancer Therapy.
Nguyen CDK; Yi C
Trends Cancer; 2019 May; 5(5):283-296. PubMed ID: 31174841
[TBL] [Abstract][Full Text] [Related]
38. Role of Akt signaling in resistance to DNA-targeted therapy.
Avan A; Narayan R; Giovannetti E; Peters GJ
World J Clin Oncol; 2016 Oct; 7(5):352-369. PubMed ID: 27777878
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
Chen M; Wang M; Xu S; Guo X; Jiang J
Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
[TBL] [Abstract][Full Text] [Related]
40. Human Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical Cancer.
Jung HS; Rajasekaran N; Ju W; Shin YK
J Clin Med; 2015 May; 4(5):1126-55. PubMed ID: 26239469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
